AIM-HIGH Trial
Study / Research
A large cardiovascular outcomes trial that showed no cardiovascular benefits from niacin therapy.
Mentioned in 2 videos
Save the 2 videos on AIM-HIGH Trial to your own pod.
Sign up free to keep building your knowledge base on AIM-HIGH Trial as more episodes are added.
Videos Mentioning AIM-HIGH Trial
#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain
Peter Attia MD
A large randomized, prospective, blinded trial designed to test the effect of adding niacin to statin therapy to raise HDL-C in patients with optimized LDL-C. It failed to show additional cardiovascular event reduction despite lowering ApoB.
210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
Peter Attia MD
A large cardiovascular outcomes trial that showed no cardiovascular benefits from niacin therapy.